Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-008552
Filing Date
2025-03-18
Accepted
2025-03-18 20:45:09
Documents
1
Period of Report
2025-03-15

Document Format Files

Seq Description Document Type Size
1 form4-03182025_080306.html 4  
1 form4-03182025_080306.xml 4 6447
  Complete submission text file 0001415889-25-008552.txt   8004
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Issuer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O STRUCTURE THERAPEUTICS INC. 611 GATEWAY BLVD, SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address
Lin Xichen (Reporting) CIK: 0001962926 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41608 | Film No.: 25750555